What are Vasodilators drugs?

Vasodilators drugs are pharmacologic agents that share a common mechanism (typically targeting Vasculature and cardiac function). 2 are currently marketed, with 1 more in clinical development.

What are the marketed Vasodilators drugs?

Marketed Vasodilators drugs include BiDil XR, Vasoactive drug therapy.

Vasodilators

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

2 marketed 1 in Phase 2

This page covers all Vasodilators drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Vasculature and cardiac function.

Targets

Vasculature and cardiac function

Marketed (2)

BiDil XR · Arbor Pharmaceuticals, Inc. · Cardiovascular
BiDil XR combines isosorbide dinitrate and hydralazine to enhance vasodilation and reduce cardiac workload, specifically benefiting patients with heart failure.
Vasoactive drug therapy · Second Affiliated Hospital, School of Medicine, Zhejiang University · Cardiovascular
Vasoactive drug therapy uses pharmacological agents to modulate vascular tone and blood flow by acting on smooth muscle and endothelial function.

Phase 2 pipeline (1)

Etamin · Cardiovascular
Etamin works by releasing nitric oxide, which relaxes blood vessel muscles and causes blood vessels to widen.

Patent intelligence

vasodilators patent landscape — aggregated cliff calendar, attackable patents, originator estates